Axxcess Wealth Management LLC Sells 6,457 Shares of Zoetis Inc. (NYSE:ZTS)

Axxcess Wealth Management LLC trimmed its position in shares of Zoetis Inc. (NYSE:ZTS) by 65.7% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,369 shares of the company’s stock after selling 6,457 shares during the quarter. Axxcess Wealth Management LLC’s holdings in Zoetis were worth $584,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently modified their holdings of ZTS. Aveo Capital Partners LLC purchased a new stake in shares of Zoetis in the 4th quarter worth $225,000. Gryphon Financial Partners LLC increased its stake in shares of Zoetis by 11.8% in the 4th quarter. Gryphon Financial Partners LLC now owns 3,056 shares of the company’s stock worth $601,000 after purchasing an additional 322 shares in the last quarter. Jump Financial LLC purchased a new stake in shares of Zoetis in the 4th quarter worth $339,000. TrinityPoint Wealth LLC increased its stake in shares of Zoetis by 0.3% in the 4th quarter. TrinityPoint Wealth LLC now owns 22,319 shares of the company’s stock worth $4,405,000 after purchasing an additional 73 shares in the last quarter. Finally, Franklin Resources Inc. increased its stake in shares of Zoetis by 8.9% in the 4th quarter. Franklin Resources Inc. now owns 161,489 shares of the company’s stock worth $31,873,000 after purchasing an additional 13,236 shares in the last quarter. 92.80% of the stock is currently owned by hedge funds and other institutional investors.

Zoetis Trading Down 0.3 %

Shares of ZTS stock opened at $192.73 on Friday. Zoetis Inc. has a 12-month low of $144.80 and a 12-month high of $201.92. The company has a current ratio of 3.45, a quick ratio of 2.09 and a debt-to-equity ratio of 1.32. The stock’s 50-day moving average price is $184.70 and its 200-day moving average price is $174.47. The stock has a market capitalization of $87.94 billion, a price-to-earnings ratio of 37.13, a price-to-earnings-growth ratio of 2.98 and a beta of 0.88.

Zoetis (NYSE:ZTS) last issued its earnings results on Tuesday, August 6th. The company reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.49 by $0.07. Zoetis had a return on equity of 50.67% and a net margin of 26.29%. The firm had revenue of $2.36 billion for the quarter, compared to analysts’ expectations of $2.31 billion. During the same period in the previous year, the firm posted $1.41 earnings per share. The business’s revenue was up 8.3% compared to the same quarter last year. Equities research analysts predict that Zoetis Inc. will post 5.84 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. Stifel Nicolaus upped their price objective on Zoetis from $200.00 to $210.00 and gave the stock a “buy” rating in a research note on Wednesday. Piper Sandler increased their price target on Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 14th. Argus upgraded Zoetis to a “strong-buy” rating in a research note on Friday, August 9th. Finally, BTIG Research increased their price target on Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, August 12th. Nine research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Buy” and a consensus price target of $220.38.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.